SCI & TECH● LOWAug 30 · Aug 30, 2026, 8:01 PM
Bayer’s AskBio completes enrollment in Phase 2 heart failure gene therapy trial
Seeking Alpha Tech · global
Bayer's AskBio has successfully completed patient enrollment for its Phase 2 clinical trial of a gene therapy for heart failure. This marks a significant step in the development of a potential new medical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH45m agoJapan launches mission to bring back samples from Mars’s moon PhobosEuroNews [en]SCI & TECH51m agoJapan launches mission to explore Mar moons and bring back samplesjapanherald.com · JapanSCI & TECH1h ago"Power is probably the forever bottleneck": Grid delays threaten the AI race.AxiosSCI & TECH1h agoI let agents plan a WNBA finals trip (but kept my wallet to myself)Axios